ClinConnect ClinConnect Logo
Search / Trial NCT06732102

Philly CEAL- DECIDE+ Adaptation

Launched by UNIVERSITY OF PENNSYLVANIA · Dec 9, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Community Health Worker Chronic Disease Management Cardiovascular Health Unmet Social Needs

ClinConnect Summary

The Philly CEAL-DECIDE+ Adaptation trial is studying how an enhanced program for community health workers (CHWs) can help people in Philadelphia manage their heart health better. This is especially important because heart disease affects many racial and ethnic minorities and underserved communities. The study will involve 500 residents aged 35 to 75 who have risk factors for heart disease, such as high blood pressure or diabetes, and who have unmet social needs like trouble with housing or food security. Participants will either take part in the DECIDE+ program, which includes group sessions and consultations with a CHW, or continue with standard CHW services.

To be eligible for the study, individuals must live in Philadelphia, be within the specified age range, have been told by a healthcare provider that they have a heart disease-related condition, and have at least one unmet social need. Participants can expect to attend nine group sessions and have regular consultations to help them improve their heart health and address any social challenges they face. This trial aims to find effective ways to support heart health while also considering the important social factors that can impact health outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Reside in Philadelphia
  • Be between 35 and 75 years of age (inclusive)
  • * Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
  • 1. Pre-diabetes
  • 2. Diabetes
  • 3. Hypertension
  • 4. Hyperlipidemia/ high cholesterol)
  • 5. BMI \>=30.
  • Have completed an initial visit with a CEO CHW
  • * Have one or more unmet social needs identified in the CEO Intake Form in the following areas:
  • 1. Housing Stability,
  • 2. Food security,
  • 3. Transportation to medical appointments and/or work, employment,
  • 4. Household utilities,
  • 5. Healthcare access,
  • 6. Health literacy, and
  • 7. Social support.
  • Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
  • Exclusion Criteria:
  • Does not reside in Philadelphia
  • Not between 35 and 75 years of age (inclusive)
  • * Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
  • 1. Pre-diabetes
  • 2. Diabetes
  • 3. Hypertension
  • 4. Hyperlipidemia/ high cholesterol)
  • 5. BMI \>=30.
  • Has not completed an initial visit with a CEO CHW
  • * Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas:
  • 1. Housing Stability,
  • 2. Food security,
  • 3. Transportation to medical appointments and/or work, employment,
  • 4. Household utilities,
  • 5. Healthcare access,
  • 6. Health literacy, and
  • 7. Social support.
  • Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Jose Bauermeister, MPH, PhD

Principal Investigator

University of Pennsylvania

Antonia Villarruel, RN, PhD

Principal Investigator

University of Pennsylvania

Carmen Alvarez, RN, PhD

Principal Investigator

University of Pennsylvania

Stephen Bonett, RN, PhD

Principal Investigator

University of Pennsylvania

Ashley Clemmons

Principal Investigator

Office of Community Empowerment and Opportunity

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported